Arimidex 1 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DR26F1G38
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,643
Award facts
- Contract value 100% obligated
- $22,642.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,642.90 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packages) on November 7, 2025, with an ultimate completion date of November 10, 2025. This firm fixed-price delivery order represents a non-competitive procurement and was placed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement extending through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement across the Department of Defense and Veterans Affairs healthcare systems.
The delivery order will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. As a child order under the SPE2DX global pharmaceutical support contract, this award demonstrates the vendor's role in supplying specialized medications to support military healthcare programs. The SPE2DX vehicle enables AmerisourceBergen to provide a comprehensive range of pharmaceutical products, including specialty medications and brand-name drugs, to customers including the Defense Health Agency and U.S. Coast Guard. This delivery order for Arimidex, a hormone-therapy medication, reflects the company's ongoing capability to fulfill federal medical supply requirements across multiple therapeutic domains under the DLA's pharmaceutical prime vendor framework.
Quick answers
Who was awarded contract SPE2DR26F1G38?
SPE2DR26F1G38 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26F1G38 worth?
The government has obligated $22,643 on SPE2DR26F1G38.
Is contract SPE2DR26F1G38 an order under another contract?
Yes. SPE2DR26F1G38 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1G38 competed?
The extent of competition for SPE2DR26F1G38 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award